ENTITY
RPG Life Sciences

RPG Life Sciences (RPGL IN)

7
Analysis
Health Care • India
RPG Life Sciences Ltd. develops, manufactures and markets branded drugs, bulk drugs, and generics.
more
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Logo
5.1k Views
Share
•01 Mar 2015 23:26

India's Budgets: 2006-2015. Key Charts, and Key questions

In continuation of my work of detailed work on India Budget for last ten years, this piece through simple charts puts in perspective: Ā 2014 Actual...

Share
bearish•Sagility India
•26 May 2025 22:46

Sagility India IPO Lockup - US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

Sagility B.V. plans to offload up to 15.02% stake in Sagility India via block deals worth INR26.7bn (US$314.7m). The secondary share sale is priced...

Logo
1.1k Views
Share
bearish•Anthem Biosciences
•19 Mar 2025 10:58

Anthem Biosciences Pre-IPO - The Negatives- Margins Aren't There Yet

Anthem Biosciences is looking to raise up to US$400m in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.

Logo
444 Views
Share
bearish•RPG Life Sciences
•21 Jun 2021 22:00•Syndicated

RPG Life Sciences (NOT RATED): Annual investor conference takeaways

RPGL reported revenue growth, margin expansion and debt reduction in FY21 despite Covid-led disruptions in the acute portfolio

Share
x